Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0007582-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q252*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	2	47639661	47639661	C	T	2:g.47639661C>T	ENST00000233146.2:c.754C>T	0.12		134	945		151	5	4/16		Pathogenic	rs63750347			82		NO		0.4111						LUAD		1.03		1	Male			Matched	4.89359848807					IMPACT410																							1:Progressed																	0.41	Commercial	2	4.716981132		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0010736-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L223Tfs*10	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	2	47639574	47639613	CTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAG	-	2:g.47639574_47639613del	ENST00000233146.2:c.667_706del	0.26		131	373		250	26	4/16						78		YES		0.1351						LUAD		9.8		1	Male			Matched	25.446712138					IMPACT410																							1:Progressed																	0.14	Clinical trial	1	24.52830189		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s60	Lung cancer	Lung Adenocarcinoma	S494*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP			NA	NA	MSKCC	2	47690264	47690264	C	G	2:g.47690264C>G	ENST00000233146.2:c.1481C>G	0.21		18	68			1469	9/16		Pathogenic	rs370970617					Durable Clinical Benefit			Non-Squamous			1358		LUAD		24.3121		1	Female			Matched	49.1																												0:Censor					73	PR	0	A*30:01	A*02:01	B*44:02	B*13:02	C*05:01	C*06:02	15.0	4350	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007236-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X669_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	2	47702410	47702410	G	T	2:g.47702410G>T	ENST00000233146.2:c.2005+1G>T							19			Likely_pathogenic	rs267607986			63				0.3036						LUAD				1	Male	Current heavy		Matched	17.6169545571			NO	EGFR	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	534	YES	Primary		IV	NO	YES	20	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007582-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q252*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47639661	47639661	C	T	2:g.47639661C>T	ENST00000233146.2:c.754C>T							5	4/16		Pathogenic	rs63750347			81		NO		0.4111						LUAD				1	Male	Never		Matched	4.89359848807			NO	EGFR	IMPACT410	YES	MSKCC	2	Liver	Adenocarcinoma	Lung	YES	Tumor	780	NO	Metastasis		IIIA	YES	YES	50	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008404-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	MSH2-intragenic	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	fusion	DELETION	Diploid				MSKCC-DMP	NA	-1												13							63				0.5499						LUAD				2	Male	Former heavy		Matched	12.723356069			NO	MAP2K1	IMPACT410	NO	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	931	NO	Metastasis		IIIB	NO	YES	80	AWD																													
Lung Adenocarcinoma (MSKCC, Science 2015)	Y2087	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D597V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.02;Polyphen-2: impact: benign, score: 0.261	Missense_Mutation	SNP			NA	NA	NA	2	47702194	47702194	A	T	2:g.47702194A>T	ENST00000233146.2:c.1790A>T	0.18		18	83		81	491	12/16		Uncertain_significance	rs548407418		3	68	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9315	Adenocarcinoma	Transversion Low	358	507	Self reported self status	LUAD	Weak(1-49% membraneous staining	8.3	5	1	Female	Never	0	Matched	16.3666666667	914	SD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0000681-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L94V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.981	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	2	47635608	47635608	C	G	2:g.47635608C>G	ENST00000233146.2:c.280C>G	0.17		154	733		367	24	2/16		Uncertain_significance	rs1330621664			68		NO		0.0440						LUAD		5.47		1	Female			Matched	23.4892727428					IMPACT410																							1:Progressed																	0.04	Commercial	3	22.64150943	50	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S87C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: probably_damaging, score: 0.943	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	2	47635588	47635588	C	G	2:g.47635588C>G	ENST00000233146.2:c.260C>G	0.53		447	398		400	90	2/16	0.000007088478387229397	Uncertain_significance	rs587781447			53		YES		0.5235						LUAD		13.17		1	Male			Matched	96.496511152					IMPACT341																							1:Progressed																	0.52	Commercial	2	91.83673469		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	I192F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.364	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	2	47637440	47637440	A	T	2:g.47637440A>T	ENST00000233146.2:c.574A>T	0.55		473	392		388	90	3/16	0.0000119304	Uncertain_significance	rs768006988			53		YES		0.5235						LUAD		13.17		1	Male			Matched	96.496511152					IMPACT341																							1:Progressed																	0.52	Commercial	2	91.83673469		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0003869-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E562Q	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.04;Polyphen-2: impact: possibly_damaging, score: 0.457	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	2	47698126	47698126	G	C	2:g.47698126G>C	ENST00000233146.2:c.1684G>C	0.19		132	571		342	56	11/16	0.0000070987939149138565	Uncertain_significance	rs1114167816			66		NO		0.3305						LUAD		5.47		1	Female			Matched	54.8083030664					IMPACT410																							1:Progressed																	0.33	Clinical trial	1	52.83018868	0	Ever	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001613-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	F58L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.992	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47630504	47630504	C	G	2:g.47630504C>G	ENST00000233146.2:c.174C>G							5	1/16	0.0000128679	Uncertain_significance	rs372189599			60		YES		0.0056						LUAD				2	Female	Never		Matched	5.54577650299			NO	EGFR	IMPACT341	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	458	YES	Primary		IV	YES	YES		DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004643-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E16A	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.724	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47630377	47630377	A	C	2:g.47630377A>C	ENST00000233146.2:c.47A>C							13	1/16		Uncertain_significance	rs745771647			68				0.0027						LUAD				1	Male	Former heavy		Matched	12.723356069			YES	NF1_truncating	IMPACT410	YES	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	365	YES	Primary		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005985-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	T441N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.38;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47672732	47672732	C	A	2:g.47672732C>A	ENST00000233146.2:c.1322C>A							8	8/16						50		YES		0.5977						LUAD				1	Female	Never		Matched	7.82975758092			NO	EGFR	IMPACT410	NO	MSKCC	1	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	851	NO	Metastasis		IV	YES	NO		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009837-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q158R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.177	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47637339	47637339	A	G	2:g.47637339A>G	ENST00000233146.2:c.473A>G							6	3/16		Uncertain_significance				71				0						LUAD				1	Female	Former heavy		Matched	5.87231818569			NO	KRAS	IMPACT410	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	1067	NO	Primary		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007131-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V605F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.22;Polyphen-2: impact: benign, score: 0.007	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47702217	47702217	G	T	2:g.47702217G>T	ENST00000233146.2:c.1813G>T							11	12/16	0.00000397655	Uncertain_significance	rs730881777	0.000058		50				0.0876						LUAD				2	Female	Former light		Matched	10.7659166738			NO	FGFR3-TACC3	IMPACT410	NO	MSKCC	1	Chest Wall	Adenocarcinoma	Lung	YES	Tumor	509	NO	Metastasis	Note: The CDK12 and ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	NO	YES		DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009223-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	H428L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: possibly_damaging, score: 0.716	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47672693	47672693	A	T	2:g.47672693A>T	ENST00000233146.2:c.1283A>T							37	8/16						68				0.0853						LUAD				1	Male	Former heavy		Matched	36.2126288117			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	881	YES	Metastasis		IV	NO	YES	10	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001986-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	T807A	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.17;Polyphen-2: impact: benign, score: 0.033	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47705619	47705619	A	G	2:g.47705619A>G	ENST00000233146.2:c.2419A>G							8	14/16		Uncertain_significance				58				0.2075						LUAD				1	Female	Former heavy		Matched	8.87324240478			NO	UNKNOWN DRIVER	IMPACT341	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	425	NO	Primary		IIIA	NO	YES	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000681-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L94V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.981	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47635608	47635608	C	G	2:g.47635608C>G	ENST00000233146.2:c.280C>G							17	2/16		Uncertain_significance	rs1330621664			66		NO		0.0581						LUAD				2	Female	Former heavy		Matched	18.8556401102			NO	EGFR	IMPACT341	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	834	NO	Metastasis		IV	YES	YES	75	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000681-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L94V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.981	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47635608	47635608	C	G	2:g.47635608C>G	ENST00000233146.2:c.280C>G							24	2/16		Uncertain_significance	rs1330621664			66		NO		0.0440						LUAD				2	Female	Former heavy		Matched	23.4892727428			NO	EGFR	IMPACT410	YES	MSKCC	2	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	817	NO	Metastasis	Note: The EIF4A2 exon8 mutations all occur in cis (same allele).              Note: The FGFR4, NSD1, FLT4 copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically	IV	YES	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S87C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: probably_damaging, score: 0.943	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47635588	47635588	C	G	2:g.47635588C>G	ENST00000233146.2:c.260C>G							90	2/16	0.000007088478387229397	Uncertain_significance	rs587781447			51				0.5235						LUAD				1	Male	Former heavy		Matched	96.496511152			YES	PIK3CA	IMPACT341	YES	MSKCC	1	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	1189	NO	Metastasis		IIIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	I192F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.364	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	2	47637440	47637440	A	T	2:g.47637440A>T	ENST00000233146.2:c.574A>T							90	3/16	0.0000119304	Uncertain_significance	rs768006988			51				0.5235						LUAD				1	Male	Former heavy		Matched	96.496511152			YES	PIK3CA	IMPACT341	YES	MSKCC	1	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	1189	NO	Metastasis		IIIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009924-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A370S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 1;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47656912	47656912	G	T	2:g.47656912G>T	ENST00000233146.2:c.1108G>T							18	7/16						78				0.0000						LUAD				1	Male	Former heavy		Matched	17.6169545571			NO	KRAS	IMPACT410	NO	MSKCC	0	Pleura	Adenocarcinoma	Lung	YES	Tumor	982	YES	Metastasis	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	IV	NO	YES	70	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006133-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q337E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.02;Polyphen-2: impact: possibly_damaging, score: 0.85	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	2	47643501	47643501	C	G	2:g.47643501C>G	ENST00000233146.2:c.1009C>G							60	6/16		Uncertain_significance	rs63750778			75				0.0468						LUAD				1	Female	Former heavy		Matched	55.787022764			NO	MAP2K1	IMPACT410	NO	MSKCC	1	Brain	Adenocarcinoma	Lung	YES	Tumor	684	NO	Metastasis	Note: The EP300 exon19 mutations all occur in cis (same allele).	IIIB	NO	YES	30	AWD																													
